# CENTENE CORPORATION (CNC) · Edgar & Edgarette company card

> Centene (CNC) grew revenue 19.4% in FY2025 to $194.8 billion, operating margin -3.9% against a 1.3% median for hospital & medical service plans, equity 26.0% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1071739 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/CNC) · [JSON](https://www.pops4.com/boards/company/CNC.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $194.8B |
| Revenue growth, 1 year | 19.4% |
| Revenue growth per year | 11.5% |
| Operating margin | -3.9% (prior year 1.9%) |
| Net margin | -3.4% |
| Operating cash flow | $5.1B |
| Capital spending | $767M |
| Free cash flow | $4.3B |
| Cash | $17.9B |
| Long-term debt | $17.5B |
| Total assets | $76.7B |
| Total equity | $20.0B |
| Equity ÷ assets | 26.0% |
| Return on equity | -33.5% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Piotroski F: 4 of 9 (middling)
- Health Harbor boat: Sound ship · one warning sign · operating loss: a margin of -3.9% in FY2025
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $194.8B (FY2025), total debt $17.5B. Experience: revenue up 19.4% on the year, up 11.5% a year over 4 years; operating margin -3.9%, down from 1.9%. Soundness: equity 26.0% of assets, return on equity -33.5%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $198.8B and $235.8B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $184.4B to $252.4B. A statistical range, not company guidance. Against peers (10 filers, $50M+ revenue, hospital & medical service plans): operating margin -3.9% against a 1.3% median; growth 19.4% against 12.2%.

Range logged 2026-09-26, receipt 1f1f5da79edd62a3, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 5, latest 2026-08-17 ([filing](https://www.sec.gov/Archives/edgar/data/1071739/000107173926000165/0001071739-26-000165-index.htm))

## Recent filings

- 8-K · filed 2026-10-27 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1071739/000107173926000194/0001071739-26-000194-index.htm)
- 10-Q · filed 2026-10-27 · [filing](https://www.sec.gov/Archives/edgar/data/1071739/000107173926000192/0001071739-26-000192-index.htm)
- 8-K · filed 2026-10-08 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1071739/000107173926000186/0001071739-26-000186-index.htm)
- 8-K · filed 2026-09-16 · 7.01 Regulation FD Disclosure · [filing](https://www.sec.gov/Archives/edgar/data/1071739/000107173926000172/0001071739-26-000172-index.htm)
- 8-K · filed 2026-08-17 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1071739/000107173926000165/0001071739-26-000165-index.htm)
- 8-K · filed 2026-07-29 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1071739/000107173926000162/0001071739-26-000162-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001071739.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1071739

## Cite

POPS4, Edgar & Edgarette: CENTENE CORPORATION (CNC) company card, from the company's own SEC filings, accessed 2026-11-05, https://www.pops4.com/boards/company/CNC. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.